- Morgan Stanley cut the price target for ArcBest Corporation ARCB from $136 to $125. Morgan Stanley analyst Ravi Shanker maintained an Overweight rating. ArcBest shares fell 3.3% to close at $95.42 on Wednesday.
- Truist Securities increased the price target for Owens Corning OC from $105 to $135. Truist Securities analyst Keith Hughes maintained a Hold rating. Owens Corning shares fell 2.2% to close at $128.67 on Wednesday.
- Goldman Sachs increased the price target for Netflix, Inc. NFLX from $230 to $400. Goldman Sachs analyst Eric Sheridan maintained a Neutral rating. Netflix shares fell 1.2% to $440.56 in pre-market trading.
- Cantor Fitzgerald cut Regeneron Pharmaceuticals, Inc. REGN price target from $815 to $795. Cantor Fitzgerald analyst Alethia Young maintained a Neutral rating. Regeneron Pharmaceuticals shares fell 0.7% to $713.03 in pre-market trading.
- JMP Securities boosted Protagonist Therapeutics, Inc. PTGX price target from $28 to $35. JMP Securities analyst Jonathan Wolleben maintained a Market Outperform rating. Protagonist Therapeutics shares fell 1.5% to $23.05 in pre-market trading.
- Raymond James slashed Comerica Incorporated CMA price target from $57 to $53. Raymond James analyst Michael Rose maintained a Strong Buy rating. Comerica shares fell 0.5% to $43.28 in pre-market trading.
- Rosenblatt raised CME Group Inc. CME price target from $161 to $169. Rosenblatt analyst Andrew Bond maintained a Sell rating. CME Group shares fell 0.1% to $183.84 in pre-market trading.
- B of A Securities raised the price target for BorgWarner Inc. BWA from $54 to $67. B of A Securities analyst John Murphy upgraded the stock from Neutral to Buy. BorgWarner shares fell 1.7% to close at $43.18 on Wednesday.
- Keybanc boosted Meta Platforms, Inc. META price target from $280 to $335. Keybanc analyst Justin Patterson maintained an Overweight rating. Meta shares gained 2.9% to close at $294.37 on Wednesday.
- Jefferies increased Amedisys, Inc. AMED price target from $98 to $101. Jefferies analyst Brian Tanquilut downgraded the stock from Buy to Hold. Amedisys shares dropped 0.5% to $90.80 in pre-market trading.
- Citigroup raised D.R. Horton, Inc. DHI price target from $124 to $140. Citigroup analyst Anthony Pettinari maintained a Buy rating. D.R. Horton shares fell 0.8% to $118.30 in pre-market trading.
Check This Out: Alphabet, Palo Alto Networks And 2 Other Stocks Insiders Are Selling
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: NewsPrice TargetSmall CapPre-Market OutlookMarketsAnalyst RatingsTrading Ideasanalyst forecastsPT Changes
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in